41/242/2026 - Medications Used in Ocular and Otolaryngological Pathologies
About This Opportunity
TranslatedThis tender, identified as 41/242/2026, pertains to the procurement of medications specifically designed for the treatment of ocular and otolaryngological pathologies. The focus is on acquiring pharmaceutical products that are essential for addressing various eye and ear, nose, and throat conditions. Key requirements for bidders may include the provision of high-quality medications that meet regulatory standards, as well as the ability to deliver these products in a timely manner to designated healthcare facilities. The tender emphasizes the importance of ensuring that the medications supplied are effective and safe for patient use. Additionally, bidders may be required to demonstrate their experience in the pharmaceutical sector, particularly in relation to ocular and otolaryngological treatments. The location for the delivery of these medications will be specified in the tender documents, and it is crucial for interested parties to review all associated documentation carefully to understand the full scope of the requirements. This tender represents an opportunity for pharmaceutical companies to contribute to the healthcare sector by providing essential medications that support the treatment of patients with specific medical conditions.
This is a supplies contract in the health and medical services and information and communication technology sectors, with a focus on Pharmaceuticals. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 81,367.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PortugueseThe tender titled "41/242/2026" pertains to the procurement of medications specifically designed for the treatment of ocular and otorhinolaryngological conditions in Portugal. This initiative reflects the government's commitment to enhancing healthcare services by ensuring the availability of essential pharmaceuticals for various eye and ear, nose, and throat (ENT) disorders.
The contracting authority, although not explicitly stated, is likely to be a public health institution or agency responsible for managing healthcare provisions in Portugal. This tender is particularly significant as it seeks to address the medical needs associated with ocular and ENT pathologies, which can have a considerable impact on patient quality of life.
Typical requirements for this type of tender may include the provision of a range of medications that meet specific therapeutic criteria, adherence to stringent safety and efficacy standards, and compliance with regulatory guidelines set forth by the Portuguese health authorities. Bidders will likely be expected to demonstrate proven experience in pharmaceutical supply, robust quality assurance processes, and the capability to fulfill delivery schedules in a timely manner.
Additionally, the tender may require suppliers to maintain transparency in pricing and provide detailed documentation regarding product specifications, including ingredient sourcing and potential side effects.
This procurement opportunity underscores the vital role of pharmaceuticals in public health and aims to foster competitive bidding to ensure the best possible outcomes for patients suffering from ocular and ENT ailments across Portugal.
Data provenance
This notice is sourced from base_gov_pt and was originally published on February 11, 2026. Last refreshed 4 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Unidade Local de Saúde do Algarve, E.P.E
Unidade Local de Saúde do Algarve, E.P.E has issued 659 procurement notices on BidsFactory, including 0 currently open and 613 awarded contracts. Activity concentrates in General Supplies & Services, Health & Medical, and Information & Communication Technology. All notices are published for Portugal. Notices are distributed via base_gov_pt. Most recent publication: June 18, 2026.
Frequently asked questions about this tender
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to NOVARTIS FARMA - Produtos Farmacêuticos, SA.. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Unidade Local de Saúde do Algarve, E.P.E in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €81,367. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.